Figure 1From: Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib Changes in plasma proteins after lenvatinib treatment. The concentrations of plasma proteins were measured at baseline and at day 8 of lenvatinib treatment in individual patients, and the percentage change from baseline was plotted for each patient.Back to article page